ATE226246T1 - Stammzellen proliferationsfaktor - Google Patents

Stammzellen proliferationsfaktor

Info

Publication number
ATE226246T1
ATE226246T1 AT93911591T AT93911591T ATE226246T1 AT E226246 T1 ATE226246 T1 AT E226246T1 AT 93911591 T AT93911591 T AT 93911591T AT 93911591 T AT93911591 T AT 93911591T AT E226246 T1 ATE226246 T1 AT E226246T1
Authority
AT
Austria
Prior art keywords
stem cell
cell proliferation
cells
growth
scpf
Prior art date
Application number
AT93911591T
Other languages
English (en)
Inventor
Michael J P Lawman
Charles E Bagwell
Patricia D Lawman
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE226246T1 publication Critical patent/ATE226246T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT93911591T 1992-04-06 1993-04-06 Stammzellen proliferationsfaktor ATE226246T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86388992A 1992-04-06 1992-04-06
PCT/US1993/003197 WO1993020197A1 (en) 1992-04-06 1993-04-06 Stem cell proliferation factor

Publications (1)

Publication Number Publication Date
ATE226246T1 true ATE226246T1 (de) 2002-11-15

Family

ID=25342032

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911591T ATE226246T1 (de) 1992-04-06 1993-04-06 Stammzellen proliferationsfaktor

Country Status (11)

Country Link
EP (1) EP0672128B1 (de)
JP (2) JP3255290B2 (de)
KR (1) KR100256319B1 (de)
CN (1) CN1081715A (de)
AT (1) ATE226246T1 (de)
AU (1) AU4046793A (de)
CA (1) CA2133646C (de)
DE (1) DE69332412T2 (de)
IL (1) IL105324A0 (de)
WO (1) WO1993020197A1 (de)
ZA (1) ZA932489B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
BR0301971A (pt) 2002-06-06 2005-03-15 Goodyear Tire & Rubber Mangueira de célula de combustìvel com propriedades de barreira
KR100674783B1 (ko) * 2003-12-09 2007-01-25 (주)안트로젠 세포 이식을 위한 세포의 생산 방법
CN116064597B (zh) * 2023-01-17 2024-04-26 北京大学 通过自主复制rna实现哺乳动物细胞中的定向进化和达尔文适应

Also Published As

Publication number Publication date
EP0672128A1 (de) 1995-09-20
CA2133646C (en) 2003-07-08
CN1081715A (zh) 1994-02-09
DE69332412D1 (de) 2002-11-21
ZA932489B (en) 1994-02-17
CA2133646A1 (en) 1993-10-14
JPH07508640A (ja) 1995-09-28
EP0672128B1 (de) 2002-10-16
JP3255290B2 (ja) 2002-02-12
AU4046793A (en) 1993-11-08
IL105324A0 (en) 1993-08-18
KR100256319B1 (en) 2000-05-15
JP2001335599A (ja) 2001-12-04
WO1993020197A1 (en) 1993-10-14
EP0672128A4 (de) 1996-03-20
DE69332412T2 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
ATE274577T1 (de) Stammzellen-proliferations-faktor
EP0670369A3 (de) An menschliches programmiertes Zelltod relatiertes Peptid, und dessen kodierende DNA
ATE140968T1 (de) Kultur des wachstumsfaktors der vaskularen endothelialzellen und dns, die dafür kodiert
NZ310710A (en) Fermentative production of hydrophobic proteins such as ifn-<beta>
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
IL143266A0 (en) Transforming growth factor-beta binding proteins and pharmaceutical compositions for increasing bone mineral content utilizing the same
ATE382053T1 (de) System zur antikörperexpression und- synthese
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
SE8900247D0 (sv) Amphiregulin: a novel bifunctional growth modulating glycoprotein
CA2395343A1 (en) Use of acid-stable proteases in animal feed
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
EP0424416A4 (en) Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
CA2260365A1 (en) Differentiation-suppressive polypeptide
DE69332412D1 (de) Stammzellen proliferationsfaktor
ES2058479T3 (es) Compuestos peptidicos.
DE69728415D1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
AU2534595A (en) Angiotensin ii for improving fertilization
NZ333412A (en) Plant proteins treated to reduce isoflavones, manganese and nucleotides and nutritional products made therefrom
WO2002004010A3 (en) Inhibition of tumor growth by a nematode anticoagulant protein
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.
WO2003025004A3 (en) Purified bacterial polypeptides involved in nucleic acid processing
ATE231887T1 (de) Protein mit anti-tumorwirkung
WO1997025421A3 (en) PROTEIN INDUCED BY DEPRENYL$m(3)
PL292085A1 (en) Method of tanning proteinous substances, in particular those of plant origin such as proteins from iol plants and tanned proteinous substances obtained thereby

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties